Related Experiment Videos
Chronic daily bilateral headache responsive to indomethacin
1Headache Unit, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA.
Headache
|March 31, 2001
Summary
Indomethacin effectively treats several headache types, including paroxysmal hemicranias and hemicrania continua. A trial of indomethacin is recommended for primary headaches unresponsive to standard treatments.
Area of Science:
- Neurology
- Pharmacology
Background:
- Indomethacin is a well-established treatment for specific headache disorders like chronic paroxysmal hemicrania and hemicrania continua.
- Its efficacy in other idiopathic stabbing headaches is less consistent.
Observation:
- Two cases illustrate indomethacin's effectiveness in less common headache presentations.
- Case 1: New-onset chronic daily bilateral headache, aggravated by coughing, responded to indomethacin.
- Case 2: Hemicrania continua, evolving into bilateral continuous pain, remained responsive to indomethacin.
Findings:
- Indomethacin demonstrated significant efficacy in two distinct headache cases.
- The drug successfully managed both chronic daily headache with cough exacerbations and evolving hemicrania continua.
- These cases suggest potential broader responsiveness of idiopathic primary headaches to indomethacin.
Implications:
- Indomethacin may be effective for a wider range of idiopathic primary headache disorders than currently recognized.
- A trial of indomethacin should be considered for primary headaches refractory to conventional therapies.
- This highlights the importance of considering specific pharmacologic agents for challenging headache presentations.